Cell & Gene Therapy Raw Materials: Getting it Right from the Start
Richard A Dennett, Valérie Pimpaneau and François Gianelli
Understanding the definition of raw and starting materials and the impact this has on the regulation and commercialization of your gene and
cell therapies is essential. To help shed light on this critical topic, Cell and Gene Therapy Insights spoke with members of the CMC team (Richard Dennett, Valérie Pimpaneau and François Gianelli) at Voisin Consulting Life Sciences who partner with Biotech, Pharma and Medtech manufacturers to develop, register and launch innovative products in North American and European markets.